Full-Time

Corporate Securities Counsel

Confirmed live in the last 24 hours

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

Compensation Overview

$171k - $240k/yr

Expert

San Diego, CA, USA + 1 more

More locations: Halifax Regional Municipality, NS, Canada

Preferably based in California, as indicated by the requirement for a state bar membership.

Category
Legal
Legal & Compliance
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Resmed referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Juris Doctor (JD) degree from an accredited law school.
  • Member of a state bar, preferably California, with the ability to be admitted to practice in relevant jurisdictions.
  • Minimum of 10 years of experience in corporate securities law, with a significant portion of that experience gained in-house at a public company or in a top-tier law firm.
  • In-depth knowledge of U.S. and global securities laws—particularly Australia--corporate governance principles, and regulatory requirements.
  • Experience with public company filings, including 1934 Act reports, 1933 Act offerings, and Section 16 matters.
  • Strong experience advising on capital markets transactions, mergers and acquisitions, and corporate governance.
  • Excellent written and verbal communication skills, with the ability to clearly convey complex legal concepts to non-legal stakeholders.
  • Proven ability to manage multiple priorities and navigate complex legal and business issues in a fast-paced, global environment.
  • Strong business acumen and a proactive, solution-oriented approach to legal challenges.
  • Exceptional judgment and ability to work effectively with senior executives, the board of directors, and external stakeholders.
Responsibilities
  • Provide expert legal counsel to senior management and the board of directors on matters related to United States securities laws, corporate governance, and regulatory compliance.
  • Oversee the preparation and review of public filings, including 10-Ks, 10-Qs, 8-Ks, proxy statements, and Section 16 filings (Forms 3, 4, and 5).
  • Advise on compliance with the Securities Exchange Act of 1934, the Securities Act of 1933, and other applicable regulations.
  • Coordinate with finance and internal audit on the company’s compliance with Sarbanes-Oxley (SOX) and other corporate governance standards.
  • Manage the legal aspects of the company’s capital markets transactions, including equity and debt offerings and private placements.
  • Support and coordinate with internal teams to ensure compliance with corporate governance policies, including internal controls and financial reporting requirements.
  • Counsel on executive compensation matters, including stock-based compensation and insider trading policies.
  • Familiarity and willingness to partner with our compliance function on global sustainability reporting.
  • Partner with the Investor Relations group on shareholder relations and proxy advisory issues and assist with investor communications related to securities law matters.
  • Stay informed of developments in securities law and corporate governance best practices, ensuring the company remains compliant with changing regulations.
  • Manage outside counsel relationships on securities and corporate governance issues, ensuring efficient and effective legal support.
  • Partner with business units and other departments to identify and mitigate legal risks associated with corporate securities matters.
  • Ensure compliance with SEC reporting requirements, including timely and accurate submission of all necessary filings and disclosures.
  • Secondary role supporting mergers and acquisitions activity, including integration.
Desired Qualifications
  • Experience coordinating with stock exchanges outside the United States, as well as global corporate governance requirements, particularly in Australia
  • Experience in a global organization with complex international securities law issues.
  • Knowledge of environmental, social, and governance (ESG) regulations and best practices.
  • Fluency in multiple languages (preferred but not required).

ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed's offerings include both medical devices and software subscriptions, which provide ongoing support and services. What sets ResMed apart from its competitors is its focus on reducing hospital visits and healthcare costs while improving the quality of life for patients. The company's goal is to enhance patient care and support healthcare professionals and caregivers across more than 120 countries.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Telehealth expansion aligns with ResMed's cloud-connected device strategy.
  • Rising prevalence of sleep disorders boosts demand for ResMed's products.
  • Home healthcare trend supports ResMed's focus on home-based solutions.

What critics are saying

  • Increased competition in home sleep apnea testing may impact ResMed's market share.
  • Operational challenges may delay benefits from VirtuOx acquisition.
  • Reliance on cloud-connected devices exposes ResMed to data privacy concerns.

What makes Resmed unique

  • ResMed integrates cloud-connected devices for sleep apnea and chronic disease management.
  • The acquisition of VirtuOx enhances ResMed's at-home diagnostic capabilities.
  • ResMed's NightOwl test offers a wearable, at-home solution for sleep apnea diagnosis.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

GlobeNewswire
May 1st, 2025
Resmed Acquires Virtuox

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.The acquisition reflects Resmed’s commitment to improving the way care is delivered—by making it more accessible, more coordinated, and more patient friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a simpler, more connected way.VirtuOx’s virtual testing platform helps reduce barriers to diagnosis, offering fast, flexible, and affordable options for patients—particularly those with sleep-disordered breathing or other conditions that are often underdiagnosed. For people suspected of having obstructive sleep apnea (OSA), a more streamlined, digital-first experience can make the difference between following through on testing and treatment—or falling out of the care pathway entirely.“This is about creating a simpler, more connected pathway to care,” said Justin Leong, Chief Product Officer at Resmed. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.”This acquisition strengthens Resmed’s ability to partner with healthcare providers to help streamline the diagnostic process and alleviate current bottlenecks, while expanding collaboration with home medical equipment providers to efficiently and expeditiously support patients to start treatment. It further enhances the company’s ability to serve healthcare providers with integrated tools that improve care coordination, patient engagement, and outcomes.“VirtuOx and Resmed are aligned in our focus to simplify healthcare and expand access,” said Steve Lica, CEO of VirtuOx. “Joining Resmed gives us the opportunity to scale our impact, reach and help more patients, and keep innovating on behalf of the providers and health systems we serve.”The acquisition supports a growing demand for home-based care—driven by increased awareness, convenience, and digital innovation

IR Impact
Apr 24th, 2025
Resmed names Salli Schwartz as chief investor relations officer

Healthcare technology provider Resmed has named Salli Schwartz as its chief investor relations officer.

Veye
Apr 24th, 2025
Top ASX Stocks Get a Lift Post Strong Quarters

ResMed was also recognized as one of LexisNexis "Top 100 Global Innovators."

Fierce Biotech
Apr 4th, 2025
Resmed debuts wearable, at-home sleep apnea test

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.

Medtrade
Apr 4th, 2025
Resmed Launches New Home Sleep Apnea Test

SAN DIEGO - Medtrade exhibitor Resmed has launched NightOwl(TM), a new home sleep apnea test (HSAT) that is now available across the United States.